These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29323724)

  • 21. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
    Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
    Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors.
    Chen T; Feng X
    Assay Drug Dev Technol; 2006 Aug; 4(4):473-82. PubMed ID: 16945019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new osteoclastogenesis pathway induced by cancer cells targeting osteoclast precursor cells.
    Wada A; Tsuchiya M; Ozaki-Honda Y; Kayamori K; Sakamoto K; Yamaguchi A; Ikeda T
    Biochem Biophys Res Commun; 2019 Jan; 509(1):108-113. PubMed ID: 30578079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma.
    Elmusrati AA; Pilborough AE; Khurram SA; Lambert DW
    Br J Cancer; 2017 Sep; 117(6):867-875. PubMed ID: 28742795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Action of RANKL and OPG for osteoclastogenesis.
    Kobayashi Y; Udagawa N; Takahashi N
    Crit Rev Eukaryot Gene Expr; 2009; 19(1):61-72. PubMed ID: 19191757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling.
    Kim JY; Kim JY; Kim JJ; Oh J; Kim YC; Lee MS
    Biol Pharm Bull; 2014; 37(2):255-61. PubMed ID: 24492722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.
    Yao Z; Lei W; Duan R; Li Y; Luo L; Boyce BF
    J Biol Chem; 2017 Jun; 292(24):10169-10179. PubMed ID: 28438834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
    Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
    Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
    Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction.
    Oue E; Lee JW; Sakamoto K; Iimura T; Aoki K; Kayamori K; Michi Y; Yamashiro M; Harada K; Amagasa T; Yamaguchi A
    Biochem Biophys Res Commun; 2012 Aug; 424(3):456-61. PubMed ID: 22771802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 14-3-3ζ suppresses RANKL signaling by destabilizing TRAF6.
    Ayyasamy R; Fan S; Czernik P; Lecka-Czernik B; Chattopadhyay S; Chakravarti R
    J Biol Chem; 2024 Jul; 300(7):107487. PubMed ID: 38908751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.
    Warren JT; Zou W; Decker CE; Rohatgi N; Nelson CA; Fremont DH; Teitelbaum SL
    J Cell Biochem; 2015 Nov; 116(11):2476-83. PubMed ID: 25864714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
    Zhao D; Shu B; Wang C; Zhao Y; Cheng W; Sha N; Li C; Wang Q; Lu S; Wang Y
    J Cell Biochem; 2020 Jan; 121(1):152-164. PubMed ID: 31318102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-1 Generated by Oral Squamous Cell Carcinoma Stimulates Tumor-Induced and RANKL-Induced Osteoclastogenesis: A Possible Mechanism of Bone Resorption Induced by the Infiltration of Oral Squamous Cell Carcinoma.
    Fukawa Y; Kayamori K; Tsuchiya M; Ikeda T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.